medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2018, Number 1

<< Back Next >>

Rev Mex Oftalmol 2018; 92 (1)

Amblyopia and strabismus screening program. Mexico 2016

Moguel-Ancheita S

Language: Spanish
References: 16
Page: 18-25
PDF size: 226.74 Kb.


ABSTRACT

Introduction: Based on the levels of visual disability reported by World Health Organization, has been prepared the National Campaign for Amblyopia and Strabismus in Mexico, with the Mexican Center of Strabismus, the Mexican Society of Ophthalmology, and the Mexican Council of Ophthalmology, with the objective of establishing a screening program in amblyopia in the general population. Method: A public screening program was designed in 4 phases, from the program and organization of sites, a preparatory course, to the analysis of results, from May 2016 to January 2017. Results: Ninety sites were organized in Mexico, 1,028 people were studied, aged 17.4 ± 19 years, 727 were children aged 6.7 ± 3 years. Several alerts were obtained that demonstrate the problematic and the requirements of public health. Conclusions: The high levels of visual disability in the world population requires better strategies, as demonstrated by the National Campaign for Amblyopia in Mexico. It has to be considered a permanent information to the public, facilitating access to the first-level medical service; promoting early care of vulnerable groups; medical actualization; communication with health leaders that generates cost-effective strategies for early detection and treatment, controlled by laws that results in the reduction of visual disability. Fourteen Iberomerican countries joined the campaign because finally the causes of amblyopia are the same, the lack of information is repeated, and the numbers of disability increase.


REFERENCES

  1. Organización Mundial de la Salud. Salud ocular universal. Un plan de acción mundial para 2014-2019 (revisado 15 Ene 2017). Disponible en: http://www.who.int/blindness.

  2. Leasher J, Lansingh V, Flaxman S, et al. Prevalence and causes of vision loss in Latin America and the Caribbean: 1990-2010. Br J Ophthalmol. 2014;3:1–10.

  3. Wurtz R, Kandel ER. La percepción del movimiento, la profundidad y la forma. En: Kandel ER, Scwartz JH, Jessell TM, editors. Principios de neurociencia, 27, 4.a ed. Madrid: McGraw Hill; 2000. p. 562–5.

  4. Huttenlocher PR. Synaptogenesis in human visual cortex-evidence for synapse elimination during normal development. Neurosci Lett. 1982;33:247.

  5. Norcia AM, Sampath V, Hou CH, et al. Experience expectant development of contour integration mechanisms in human visual cortex. J Vision. 2005:116–30.

  6. Fielder A. Amblyopia and disability. En: Moseley M, Fielder AR, editores. Amblyopia, a multidisciplinary approach. Oxford: Butterworth-Heinemann; 2002. p. 106–8.

  7. Packwood EA, Cruz OA, Rychwalski PJ, et al. The psychosocial effects of amblyopia study. JAAPOS. 1999;3:15–7.

  8. Hess R. Sensory processing in human amblyopia: Snakes and ladders. En: Moseley M, Fielder AR, editors. Amblyopia a multidisciplinary approach, 2. Oxford: Butterworth-Heinemann; 2002. p. 19–41.

  9. Carlton J, Karnon J, Czoski-Murray C, et al. The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: A systematic review and economic evaluation. Health Technol Assess. 2008; 12, iii, xi–194.

  10. Rahi JS, Logan S, Borja MC, et al. Prediction of improved vision in the amblyopic eye after visual loss in the non-amblyopic eye. Lancet. 2002;360:621–2.

  11. Instituto Nacional de Estadística y Geografía. Estadísticas a propósito del día internacional de las personas con discapacidad (3 de Dic) (revisado 20 Abr 2017). Disponible en: http://www.inegi.org.mx/saladeprensa/ aproposito/2015/discapacidad0.pdf.

  12. Moguel-Ancheita S, Orozco-Gómez L, Gallegos-Duarte M, et al. Cambios metabólicos en la corteza cerebral relacionados con el tratamiento de estrabismo. Resultados preliminares con SPECT. Cir Cir. 2004;72: 165–75.

  13. Moguel-Ancheita S. Estabilidad del tratamiento de la ambliopía estrábica. Rev Mex Ped. 2010;77:5–9.

  14. Moguel-Ancheita S, Ramírez-Sibaja S, Castellanos-Pérez BC, et al. Análisis de las funciones sensoriomotoras y depresión en niños con estrabismo. Primera fase. Cir Cir. 2008;76:101–8.

  15. Moguel-Ancheita S, Orozco-Gómez LP. Disfuncionalidad neuronal y psicomotora como resultado del retraso del tratamiento de la ambliopía. Cir Cir. 2007;75:481–9.

  16. Moguel-Ancheita S. Resultados del primer Día nacional de estrabismo. Día E. Rev Mex Oftalmol. 2002;76:238–42.




2020     |     www.medigraphic.com